How academic labs can approach the drug discovery process as a way to synergize with big pharma

Trends in Microbiology

Volumn 21, Issue 6, 2013, Pages 261-264

  Loregian, Arianna ^a   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DEVELOPMENT; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; HIGH THROUGHPUT SCREENING; NEGLECTED DISEASE; NOTE; PRIORITY JOURNAL; RARE DISEASE; UNIVERSITY;

ACADEMIC MEDICAL CENTERS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; UNIVERSITIES;

EID: 84878428074     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.03.006     Document Type: Note

References (15)

1. Bleicher K.H., et al. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2003, 2:369-378.
2. Hughes J.P., et al. Principles of early drug discovery. Br. J. Pharmacol. 2011, 162:1239-1249.
3. Lindsay M.A. Target discovery. Nat. Rev. Drug Discov. 2003, 2:831-838.
4. Doong S.L., et al. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:8495-8499.
5. De Clercq E. The discovery of antiviral agents: ten different compounds, ten different stories. Med. Res. Rev. 2008, 28:929-953.
6. Capizzi R.L., et al. l-Asparaginase. Annu. Rev. Med. 1970, 21:433-444.
7. Dalrymple M., et al. Academia-industry partnerships in drug discovery. Expert Opin. Drug Discov. 2006, 1:1-6.
8. Verkman A.S. Drug discovery in academia. Am. J. Physiol. Cell Physiol. 2004, 286:C465-C474.
9. Frearson J.A., Collie I.T. HTS and hit finding in academia - from chemical genomics to drug discovery. Drug Discov. Today 2009, 14:1150-1158.
10. Austin C.P., et al. NIH Molecular Libraries Initiative. Science 2004, 306:1138-1139.
11. Loregian A., Palù G. Disruption of protein-protein interactions: towards new targets for chemotherapy. J. Cell. Physiol. 2005, 204:750-762.
12. Loregian A., Coen D.M. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem. Biol. 2006, 13:191-200.
13. Muratore G., et al. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:6247-6252.
14. Tralau-Stewart C.J., et al. Drug discovery: new models for industry-academic partnerships. Drug Discov. Today 2009, 14:95-101.
15. Lessl M., et al. Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs. Drug Discov. Today 2011, 16:288-292.